ReviewO&G open2026
Secondary Postpartum Hemorrhage.
Review in O&G open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Secondary postpartum hemorrhage, defined as excessive bleeding 24 hours to 6-12 weeks after delivery, remains an uncommon but clinically significant contributor to maternal morbidity. Retained products of conception is the most common cause, and primary postpartum hemorrhage and manual placental extraction in the index delivery before admission for secondary postpartum hemorrhage are associated risk factors. Ultrasound is widely incorporated into evaluation, with an echogenic intrauterine mass representing the most predictive finding; however, diagnostic criteria are not standardized. Management varies, with many patients initially receiving antibiotics and uterotonics; however, most ultimately undergo uterine evacuation. However, the available evidence is limited by retrospective study design, highlighting the need for standardized diagnostic approaches and prospective studies to inform optimal management.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.